News Wockhardt Limited

Equities

WOCKPHARMA

INE049B01025

Delayed NSE India S.E. Other stock markets 03:40:48 2024-04-16 am EDT			5-day change	1st Jan Change
551 ^INR	+0.32%		-7.01%	+29.85%

Apr. 03	Wockhardt Limited Announces Cessation of Independent Directors	CI
Feb. 14	Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wockhardt Limited Announces Cessation of Independent Directors	Apr. 03	CI
Aziwok vs Aziwake: Delhi High Court Grants Interim Injunction In Light Of Rival Marks Being Closely Similar For Azithromycin	Mar. 08	AQ
Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Wockhardt Limited Announces Successful Completion of Pivotal Phase 3 Pneumonia Study of Its Macrolide Antibody Nafithromycin WCK 4873	Dec. 11	CI
Wockhardt Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14	CI
CARE Cuts Rating on Wockhardt's Working Capital to BB+; Outlook Negative	23-09-06	MT
Wockhardt Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Wockhardt Limited Announces Executive Changes	23-08-14	CI
CARE Keeps BBB- Rating on Wockhardt's Bank Financing	23-06-07	MT
Wockhardt Trims Consolidated Loss in Fiscal Q4	23-05-29	MT
Wockhardt Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-26	CI
INDIA STOCKS-Indian shares fall on rate-hike worries ahead of Fed, RBI minutes	23-02-22	RE
Wockhardt Widens Consolidated Net Profit in Fiscal Q3	23-02-14	MT
Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13	CI
Wockhardt Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-04	CI
CARE Keeps Rating on Wockhardt's Long-term Bank Financing, Bonds; Outlook Stable	22-09-05	MT
Wockhardt : Corp Restructuring - others	22-08-20	PU
Wockhardt Starts Global Phase 3 Clinical Study of Novel Antibiotic WCK 5222	22-08-16	MT
Wockhardt Announces Successful Initiation of Global Phase 3 Clinical Study of Its Novel Antibiotic WCK 5222	22-08-15	CI
Wockhardt Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Wockhardt Limited

Equities

WOCKPHARMA

INE049B01025

Summary

Filters